김민정 (UT Southwestern Medical Center)님 | 한빛사연구자 > 한빛사

UT Southwestern Medical Center

최종업데이트 2025.06.09.

- 김민정(UT Southwestern Medical Center)
Dual SORT LNPs for multi-organ base editing
- Nat. Biotechnol., Jun 02 2025, | https://doi.org/10.1038/s41587-025-02675-z
- 2025-06
- 바이오·의료융합
- 한빛사논문
Novel piperazine-based ionizable lipid nanoparticles allow the repeated dose of mRNA to fibrotic lungs with improved potency and safety
- Bioeng. Transl. Med., First published: 28 May 2023 | https://doi.org/10.1002/btm2.10556
- 2023-05
- 의약학
- 한빛사논문
In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables antithrombin gene editing for sustainable hemophilia A and B therapy
- Sci. Adv., 21 Jan 2022, Vol 8, Issue 3 | DOI: 10.1126/sciadv.abj6901
- 2022-01
- 의약학
- 한빛사논문, 상위피인용논문
Engineered ionizable lipid nanoparticles for targeted delivery of RNA therapeutics into different types of cells in the liver
- Sci. Adv., 26 Feb 2021, Vol. 7, no. 9, eabf4398 | DOI: 10.1126/sciadv.abf4398
- 2021-02
- 의약학
- 한빛사논문

연구자 ID

저자논문